Vorinostat, a Histone Deacetylase Inhibitor, as a Potential Novel Treatment for Psoriasis

The authors investigated the efficacy of the histone deacetylase inhibitor, Vorinostat, in targeting hyperproliferation and impaired apoptosis in psoriatic skin.